Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 125 of 6351
-
Brain cell transplant shows promise for Tough-to-Treat epilepsy
Disease control Recruiting nowThis clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve cells, called interneurons (NRTX-1001), into subjects with drug-resistant unilateral mesial temporal lobe epilepsy (MTLE), with or without mesial temporal sclero…
Phase 3 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a simple drug save kids from sepsis organ failure?
Disease control Recruiting nowThe TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).
Phase 2/3 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug SKB264 takes on tough breast cancer in Late-Stage trial
Disease control OngoingThe purpose of this study is to evaluate the efficacy of SKB264 in patients with unresectable locally advanced, recurrent or metastatic triple-negative breast cancer who have failed second-line or above prior standard of care
Phase 3 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Immunotherapy cocktail shows promise against tough throat cancer
Disease control OngoingThe purpose of this study is to explore the efficacy and safety of a combination of GP chemotherapy and tislelizumab in neoadjuvant therapy combined with tislelizumab in adjuvant therapy of locoregionally advanced nasopharyngeal carcinoma patients.
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Drug-Resistant TB: shorter Pill-Only regimen tested
Disease control OngoingMultidrug-resistant tuberculosis (MDR-TB) is tuberculosis (TB) that is resistant to at least isoniazid and rifampicin, the two most important anti-TB drugs. It occurs in 3.6% of newly diagnosed TB patients in the world and 17% of patients who have been previously treated. In 2017…
Phase 2 • Sponsor: Boston University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Womb transplant trial offers hope for women born without a uterus
Disease control Recruiting nowAbsolute Uterine Factor Infertility (AUFI) is due to congenital or surgical absence of a uterus or the presence of a nonfunctional uterus. Until 2014, the only option for women affected by Absolute Uterine Factor Infertility (AUFI) was adoption or surrogate motherhood. Uterine tr…
Sponsor: John Goss • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a malaria drug help prevent preeclampsia?
Prevention Recruiting nowThis study is prospective, single arm group ,open label, and multicenter trial (with two parallel-group \[Hydroxychloroquine 200mg with Aspirin 100mg or Aspirin 100mg\])
Phase 3 • Sponsor: Yoo-min Kim • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy hopes to fight deadly childhood brain cancers
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, and best dose of selinexor given in combination with standard radiation therapy in treating children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) or high-grade glioma (HGG) with a genetic chang…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a tiny implant fix a leaky heart valve without open surgery?
Disease control Recruiting nowAn early feasibility study to evaluate the safety and feasibility of the MRace Implant and Delivery System to treat severe mitral regurgitation and to gather preliminary data on its performance thereby providing guidance for future clinical development. The study is a single-arm …
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New shot aims to keep insulin flowing in type 1 diabetes
Disease control Stopped earlyThe objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared to placebo, along with oral Vitamin D supplementation, to preserve endogenous beta cell function and influence glycemic parameters…
Phase 3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug targets deadly immune overreaction in rare disease
Disease control Recruiting nowHemophagocytic lymphohistiocytosis is a rare, aggressive and life-threatening syndrome of excessive immune activation. Secondary hemophagocytic lymphohistiocytosis (sHLH) is the most common form of this disease and is typically associated with several other clinical conditions (e…
Phase 2/3 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New immunotherapy combo shows promise for tough lung cancer
Disease control OngoingThis study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung Cancer.
Phase 3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for Hard-to-Treat breast cancer: Dato-DXd takes on chemo
Disease control OngoingThis is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC in participants with locally recurrent inoperable or metastatic TNBC who are not candidates for PD-1/PD-L1 inhibitor therapy.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
A sponge you swallow could detect esophageal cancer before it spreads
Diagnosis Recruiting nowIn the current protocol, we propose a study to evaluate a novel, combined esophageal sponge-methylation biomarker strategy for the early detection of esophageal squamous cell carcinoma (ESCC) as well as its precursor, esophageal squamous dysplasia (ESD). This strategy leverages t…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
Can a Patient's own immune cells keep liver cancer at bay?
Disease control Recruiting nowThis is an open-label, single arm, multicenter, Phase II clinical study to investigate the efficacy and safety profiles of autologous ATL administration in HCC patients after curative treatment. Among all the eligible patients, ratio of 7:2:1 for Stage I:II:IIIa of the HCC will b…
Phase 2 • Sponsor: Lukas Biomedical Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New antibody could boost stem cell transplant success for blood disorders
Disease control OngoingBackground: Sickle cell disease (SCD) is an inherited disorder of the blood. It can damage a person s organs and cause serious illness and death. A blood stem cell transplant is the only potential cure for SCD. Treatments that improve survival rates are needed. Objective: To f…
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could removing fallopian tubes first prevent ovarian cancer without early menopause?
Prevention Recruiting nowThis is a prospective preference study that will evaluate non-inferiority of the innovative treatment (RRS with delayed RRO) as compared to the standard treatment (RRSO) with respect to high grade serous (ovarian) cancer incidence
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
New malaria vaccines show promise in protecting indonesian soldiers
Vaccine CompletedThe study is a double-blind, randomized, placebo-controlled, Phase 2 clinical trial that will assess the safety, tolerability, immunogenicity and protective efficacy of PfSPZ Vaccine and PfSPZ-CVac against naturally occurring malaria in healthy Indonesian soldiers deployed to eas…
Phase 2 • Sponsor: Sanaria Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
Could a bone marrow infusion help kidney transplant patients ditch lifelong pills?
Disease control Recruiting nowThis is a single arm phase 1 non randomized dose finding study for safety, feasibility and efficacy of deceased donor vertebral body (VB) marrow cell infusion and kidney transplantation.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a targeted pill outperform chemotherapy for childhood brain tumors?
Disease control Recruiting nowPediatric low-grade glioma (PLGG) is a heterogeneous group of WHO grade I and II brain tumors, associated with a 10-year overall survival of 90%. It is the most common form of primary central nervous system (CNS) tumor arising during childhood, adolescence and young adulthood, ac…
Phase 2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC